Corey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
Advertisement
Articles by Corey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Unmet Needs in GVHDPublished: May 4th 2021 | Updated:
Treatment for Steroid-Refractory Acute GVHDPublished: April 27th 2021 | Updated:
Final Thoughts: GVHDPublished: July 30th 2021 | Updated:
Emerging Therapies for Acute and Chronic GVHDPublished: May 4th 2021 | Updated:
Initial Therapy in GVHDPublished: April 20th 2021 | Updated:
Treatment for Steroid-Refractory Chronic GVHDPublished: April 27th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5